We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01797926
Recruitment Status : Completed
First Posted : February 25, 2013
Last Update Posted : June 12, 2017
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 25, 2013
  Study Completion Date : July 25, 2013